Melanoma antigens recognized by T cells and their use for immunotherapy.

Ohta, Shigeki; Misawa, Aya; Kyi-Tha-Thu, Chaw; Matsumoto, Naomi; Hirose, Yoshie; Kawakami, Yutaka

Ohta, Shigeki; Misawa, Aya; Kyi-Tha-Thu, Chaw; Matsumoto, Naomi; Hirose, Yoshie; Kawakami, Yutaka.

Afiliação

Ohta S; Department of Immunology, School of Medicine, International University of Health and Welfare, Chiba, Japan.
Misawa A; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
Kyi-Tha-Thu C; Department of Immunology, School of Medicine, International University of Health and Welfare, Chiba, Japan.
Matsumoto N; Department of Immunology, School of Medicine, International University of Health and Welfare, Chiba, Japan.
Hirose Y; Department of Immunology, School of Medicine, International University of Health and Welfare, Chiba, Japan.
Kawakami Y; Department of Immunology, School of Medicine, International University of Health and Welfare, Chiba, Japan.

Exp Dermatol ; 32(3): 297-305, 2023 03.

Article em En | MEDLINE | ID: mdl-36607252

Assuntos

Vacinas Anticâncer; Melanoma; Humanos; Linfócitos T; Antígenos Específicos de Melanoma; Melanoma/tratamento farmacológico; Imunoterapia; Antígenos de Neoplasias; Vacinas Anticâncer/uso terapêutico; Imunoterapia Adotiva

Palavras-chave

adoptive cell therapy; cancer immunotherapy; immune-checkpoint inhibitor; melanoma antigens; neo-antigens; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Exp Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google